Klor-con Tablet, Film Coated, Extended Release
Product Images NDC 0245-0835

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Klor-con (NDC 0245-0835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (600 mg Tablet Bottle Label)

Klor-Con 8 potassium chloride extended-release tablets, USP, 600 mg (8 mEq) film-coated oral tablets. The label indicates 100 tablets per container and is distributed by Upsher-Smith Laboratories, LLC. The storage instructions note to keep between 20° to 25°C with permitted excursions. The product package includes dosage and safety information and is marked Rx only.*

FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Label)

Label for Klor-Con 10 potassium chloride extended-release tablets, USP, 750 mg (10 mEq) strength, film-coated, oral dosage form. The package contains 100 tablets and is labeled Rx only. Manufactured and distributed by Upsher-Smith Laboratories, LLC. The label includes dosage, storage, and handling instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.